Healthcare is steadily moving away from a one-size-fits-all approach and toward something far more individualized. Increasingly, physicians and patients are exploring treatments shaped not only by diagnosis, but by factors such as age, genetics, lifestyle, hormonal balance, and long-term health risks.
This broader shift toward preventive and precision medicine is gradually gaining ground in the Philippines, particularly as conversations around healthy aging, hormone health, and chronic disease prevention become more mainstream.
At the center of that conversation is growing interest in bioidentical hormone replacement therapy, more commonly known as BHRT, alongside pharmacy compounding. Both approaches focus on tailoring treatment to the needs of individual patients rather than relying solely on standardized medications designed for large populations.
For decades, mainstream pharmaceutical care has largely operated on uniform dosing and commercially available formulations. While effective for many conditions, that model does not always account for how differently patients respond to treatment. Preventive medicine attempts to address that gap earlier, ideally before larger health complications emerge.
BHRT has become one of the more closely watched developments within that space.
Unlike traditional synthetic hormone therapies, BHRT uses hormones structurally identical to those naturally produced by the human body. According to hormone optimization specialist Dr. Neal Rouzier, treatment is not based on a single formula but on a patient’s specific hormonal profile, symptoms, and medical history.
During a recent physician training program and public forum held in Bonifacio Global City, Rouzier discussed how hormonal decline associated with aging can affect multiple systems in the body, including cardiovascular, metabolic, cognitive, and reproductive health.
“Declining hormones may be associated with increased risks of conditions such as cardiovascular disease, cognitive decline, diabetes, and other age-related concerns. BHRT, when properly evaluated and prescribed, aims to help restore hormonal balance and may support overall well-being, including bone, heart, brain, and reproductive health,” he said.
Supporters of hormone optimization point to potential benefits such as improved sleep, energy levels, metabolic function, menopause management, and quality of life. However, specialists also emphasize that BHRT is not a universal solution and requires proper medical supervision, individualized evaluation, and ongoing monitoring. Treatment suitability can vary significantly depending on a patient’s health profile, and improper hormone use may carry risks.
Alongside BHRT, pharmacy compounding is also gaining attention as part of personalized healthcare.
Unlike mass-produced medications, compounded medicines are prepared to meet the specific requirements of individual patients. This can involve adjusting dosage strengths, removing allergens, combining ingredients, or creating alternative delivery formats such as creams, capsules, or troches, medicated lozenges designed to dissolve slowly in the mouth.
Compounding can also help address medication shortages or provide alternatives for treatments that are no longer commercially available. The process follows regulated pharmaceutical standards intended to ensure consistency, safety, and quality control.
Despite growing global interest in precision medicine, adoption in the Philippines remains relatively limited. One of the primary barriers is the lack of structured physician training in hormone optimization and personalized treatment strategies.
Rouzier noted that the field itself has evolved through years of continuing education, research, and clinical application. Expanding physician training, he said, will be critical if preventive and individualized medicine is to become more integrated into mainstream healthcare.
Private sector groups have also begun investing in physician education around personalized medicine in Southeast Asia.
Among them is ASL Pharma, a Malaysia-based organization specializing in premium pharmacy compounding and individualized therapies. With more than 15 years of regional experience, the company has been working with physicians across Southeast Asia to expand clinical knowledge surrounding BHRT and preventive care.
Recently, ASL Pharma conducted a 2.5-day physician training program in the Philippines, followed by a public forum aimed at increasing awareness of hormone health and preventive medicine. The initiative brought together healthcare professionals interested in expanding their understanding of personalized treatment approaches.
Rouzier is expected to return in August for another round of advanced physician training sessions focused on more detailed clinical applications in hormone optimization.
As conversations around aging and long-term wellness continue to evolve, preventive medicine is becoming increasingly relevant for Filipinos looking for more proactive approaches to healthcare.
Ultimately, the growing interest in BHRT and pharmacy compounding reflects a broader shift in medicine itself, one that places greater emphasis not just on treating illness, but on supporting long-term health through more individualized care.